Search Results

Filter
  • 1-10 of  17 results for ""PROARRHYTHMIA""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology.

Subjects: Policy Making* ; Practice Guidelines as Topic*; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*adverse effects

  • Source: European heart journal [Eur Heart J] 2000 Aug; Vol. 21 (15), pp. 1216-31.Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Print ISSN: 0195-668X

Record details

×
Academic Journal

2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/surgery ; Catheter Ablation*/Catheter Ablation*/Catheter Ablation*/methods ; Societies, Medical*

  • Source: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing [J Interv Card Electrophysiol] 2024 Aug; Vol. 67 (5), pp. 921-1072.Publisher: Springer Country of Publication: Netherlands NLM ID: 9708966 Publication Model: Print Cited Medium: Internet ISSN: 1572-8595

Record details

×
Academic Journal

QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small-Molecule New Drug Applications Approved During 2011-2019.

  • Authors : Cohen-Rabbie S; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science, AstraZeneca, BioPharmaceuticals R&D, Cambridge, UK.; Berges AC

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Drug Approval/Drug Approval/Drug Approval/*statistics & numerical data ; Long QT Syndrome/Long QT Syndrome/Long QT Syndrome/*chemically induced

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2021 Aug; Vol. 61 (8), pp. 1106-1117. Date of Electronic Publication: 2021 Apr 12.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

×
Academic Journal

Five years of the CiPA project (2013-2018) - what did we learn?

Subjects: CARDIAC arrest; ION channelsEUROPE; UNITED States; JAPAN

  • Source: Translational & Clinical Pharmacology; Dec2018, Vol. 26 Issue 4, p145-149, 5p

Record details

×
Editorial & Opinion

Are Regulators Talking to Each Other Across Borders?

  • Authors : van der Graaf PH; Certara, Canterbury, UK.; University of Leiden, Leiden, The Netherlands.

Subjects: International Cooperation*; Drug Development/Drug Development/Drug Development/*legislation & jurisprudence ; Legislation, Drug/Legislation, Drug/Legislation, Drug/*organization & administration

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Mar; Vol. 107 (3), pp. 481-483.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print Cited Medium: Internet ISSN: 1532-6535

Record details

×
  • 1-10 of  17 results for ""PROARRHYTHMIA""